• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性神经病与全因死亡率和心血管死亡率的关系,按糖尿病状态分层的心血管疾病事件。

Associations of polyneuropathy with risk of all-cause and cardiovascular mortality, cardiovascular disease events stratified by diabetes status.

机构信息

Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Division of Cardiology, Department of Internal Medicine, St Vincent's Hospital, The Catholic University of Korea, Suwon, Korea.

出版信息

J Diabetes Investig. 2023 Nov;14(11):1279-1288. doi: 10.1111/jdi.14063. Epub 2023 Jul 30.

DOI:10.1111/jdi.14063
PMID:37517075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10583645/
Abstract

AIMS/INTRODUCTION: We investigated the association of polyneuropathy (PN) with all-cause and cardiovascular (CV) mortality and with cardiovascular disease (CVD) events stratified by diabetes status.

MATERIALS AND METHODS

This prospective cohort study used the UK Biobank. Polyneuropathy was defined based on nurse-led interviews or ICD codes for polyneuropathy. Cox proportional hazards models were used to investigate the association of polyneuropathy with clinical outcomes.

RESULTS

A total of 459,127 participants were included in the analysis. Polyneuropathy was significantly associated with all-cause and cardiovascular mortality, and with CVD events even after adjusting for CVD risk factors across all diabetes statuses. Metabolic parameters HbA , waist circumference, BMI and the inflammatory parameter C-reactive protein showed significant mediation effects for the association between polyneuropathy and CVD. Adherence to a favorable lifestyle was associated with a lower risk of all-cause and cardiovascular mortality regardless of polyneuropathy status.

CONCLUSIONS

Polyneuropathy was associated with all-cause and cardiovascular mortality, and with CVD events in subjects with diabetes or prediabetes, even those having normal glucose tolerance. This study suggests the importance of polyneuropathy as a risk factor for death and highlights the necessity of early diagnosis and lifestyle intervention for those with type 2 diabetes and polyneuropathy.

摘要

目的/引言:我们研究了多发性神经病(PN)与全因和心血管(CV)死亡率以及按糖尿病状态分层的心血管疾病(CVD)事件的相关性。

材料与方法

本前瞻性队列研究使用了英国生物库。多发性神经病是根据护士主导的访谈或 ICD 编码定义的。Cox 比例风险模型用于研究多发性神经病与临床结局的相关性。

结果

共有 459127 名参与者纳入分析。多发性神经病与全因和心血管死亡率以及 CVD 事件显著相关,即使在所有糖尿病状态下调整 CVD 危险因素后也是如此。代谢参数 HbA1c、腰围、BMI 和炎症参数 C 反应蛋白对多发性神经病与 CVD 之间的相关性具有显著的中介作用。无论多发性神经病的状态如何,遵循有利的生活方式与全因和心血管死亡率降低相关。

结论

多发性神经病与糖尿病或糖尿病前期患者的全因和心血管死亡率以及 CVD 事件相关,即使这些患者的血糖正常。本研究表明多发性神经病作为死亡风险因素的重要性,并强调了对 2 型糖尿病和多发性神经病患者进行早期诊断和生活方式干预的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be13/10583645/a8be00db8192/JDI-14-1279-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be13/10583645/a8be00db8192/JDI-14-1279-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be13/10583645/a8be00db8192/JDI-14-1279-g002.jpg

相似文献

1
Associations of polyneuropathy with risk of all-cause and cardiovascular mortality, cardiovascular disease events stratified by diabetes status.多发性神经病与全因死亡率和心血管死亡率的关系,按糖尿病状态分层的心血管疾病事件。
J Diabetes Investig. 2023 Nov;14(11):1279-1288. doi: 10.1111/jdi.14063. Epub 2023 Jul 30.
2
Body Weight Variability and Risk of Cardiovascular Outcomes and Death in the Context of Weight Loss Intervention Among Patients With Type 2 Diabetes.体重变化与 2 型糖尿病患者减肥干预中心血管结局和死亡风险
JAMA Netw Open. 2022 Feb 1;5(2):e220055. doi: 10.1001/jamanetworkopen.2022.0055.
3
Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population.代谢综合征组分与肥胖人群多发性神经病的相关性。
JAMA Neurol. 2016 Dec 1;73(12):1468-1476. doi: 10.1001/jamaneurol.2016.3745.
4
Association of sleep patterns and cardiovascular disease risk is modified by glucose tolerance status.睡眠模式与心血管疾病风险的关联受葡萄糖耐量状态的影响。
Diabetes Metab Res Rev. 2023 Sep;39(6):e3642. doi: 10.1002/dmrr.3642. Epub 2023 Apr 6.
5
The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease.基线风险对2型糖尿病合并有症状心血管疾病患者糖化血红蛋白(HbA1c)与新发心血管事件风险及死亡率之间关系的影响。
Cardiovasc Diabetol. 2016 Jul 19;15(1):101. doi: 10.1186/s12933-016-0418-1.
6
Influence of a diet and/or exercise intervention on long-term mortality and vascular complications in people with impaired glucose tolerance: Da Qing Diabetes Prevention Outcome study.饮食和/或运动干预对糖耐量受损人群长期死亡率和血管并发症的影响:大庆糖尿病预防结局研究。
Diabetes Obes Metab. 2024 Apr;26(4):1188-1196. doi: 10.1111/dom.15413. Epub 2024 Jan 2.
7
Associations Between Diabetes and Both Cardiovascular Disease and All-Cause Mortality Are Modified by Grip Strength: Evidence From UK Biobank, a Prospective Population-Based Cohort Study.握力可改变糖尿病与心血管疾病及全因死亡率之间的关联:来自英国生物库的前瞻性基于人群队列研究的证据。
Diabetes Care. 2017 Dec;40(12):1710-1718. doi: 10.2337/dc17-0921. Epub 2017 Oct 6.
8
Association of Serum 25-Hydroxyvitamin D With Cardiovascular Outcomes and All-Cause Mortality in Individuals With Prediabetes and Diabetes: Results From the UK Biobank Prospective Cohort Study.血清25-羟基维生素D与糖尿病前期和糖尿病患者心血管结局及全因死亡率的关联:英国生物银行前瞻性队列研究结果
Diabetes Care. 2022 May 1;45(5):1219-1229. doi: 10.2337/dc21-2193.
9
Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study.胰岛素抵抗与心血管疾病风险的关系因葡萄糖耐量状态而异:一项全国性前瞻性队列研究。
Diabetes Care. 2022 Aug 1;45(8):1863-1872. doi: 10.2337/dc22-0202.
10
Diabetes modifies the association of prehypertension with cardiovascular disease and all-cause mortality.糖尿病改变了高血压前期与心血管疾病和全因死亡率的关联。
J Clin Hypertens (Greenwich). 2021 Jun;23(6):1221-1228. doi: 10.1111/jch.14246. Epub 2021 Apr 4.

引用本文的文献

1
Increased blood urea nitrogen levels and compromised peripheral nerve function in patients with type 2 diabetes.2型糖尿病患者血尿素氮水平升高及周围神经功能受损。
World J Diabetes. 2025 Apr 15;16(4):101966. doi: 10.4239/wjd.v16.i4.101966.
2
Glucagon: a potential protective factor against peripheral nerve compromise in patients with type 2 diabetes and obesity.胰高血糖素:2型糖尿病和肥胖患者周围神经损伤的潜在保护因素。
Diabetol Metab Syndr. 2025 Jan 28;17(1):35. doi: 10.1186/s13098-025-01601-2.
3
Advances in diagnostic methods for early-stage diabetic polyneuropathy.

本文引用的文献

1
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.2. 糖尿病的分类和诊断:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S19-S40. doi: 10.2337/dc23-S002.
2
Association Between Fat Mass or Fat Fibrotic Gene Expression and Polyneuropathy in Subjects With Obesity: A Korean Metabolic Bariatric Surgery Cohort.肥胖患者脂肪量或脂肪纤维化基因表达与多发性神经病的关系:韩国代谢减重手术队列研究。
Front Endocrinol (Lausanne). 2022 May 16;13:881093. doi: 10.3389/fendo.2022.881093. eCollection 2022.
3
Cardiac autonomic neuropathy and risk of incident heart failure among adults with type 2 diabetes.
早期糖尿病多发性神经病的诊断方法进展。
J Diabetes Investig. 2024 Jul;15(7):820-822. doi: 10.1111/jdi.14201. Epub 2024 Apr 6.
2型糖尿病成年患者的心脏自主神经病变与发生心力衰竭的风险
Eur J Heart Fail. 2022 Apr;24(4):634-641. doi: 10.1002/ejhf.2432. Epub 2022 Jan 31.
4
Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults : A Prospective Cohort Study.美国成年人外周神经病变与全因和心血管死亡率:一项前瞻性队列研究。
Ann Intern Med. 2021 Feb;174(2):167-174. doi: 10.7326/M20-1340. Epub 2020 Dec 8.
5
Circulating Neuropeptide Y as a Biomarker for Neuromodulation in Atrial Fibrillation.循环神经肽Y作为心房颤动神经调节生物标志物
JACC Clin Electrophysiol. 2020 Nov;6(12):1575-1576. doi: 10.1016/j.jacep.2020.08.025.
6
Associations of Cardiac, Kidney, and Diabetes Biomarkers With Peripheral Neuropathy among Older Adults in the Atherosclerosis Risk in Communities (ARIC) Study.心脏、肾脏和糖尿病生物标志物与动脉粥样硬化风险社区研究(ARIC)中老年人群外周神经病变的关联。
Clin Chem. 2020 May 1;66(5):686-696. doi: 10.1093/clinchem/hvaa051.
7
Inflammation in Heart Failure: JACC State-of-the-Art Review.心力衰竭中的炎症:JACC 最新综述。
J Am Coll Cardiol. 2020 Mar 24;75(11):1324-1340. doi: 10.1016/j.jacc.2020.01.014.
8
Coronary Sinus Neuropeptide Y Levels and Adverse Outcomes in Patients With Stable Chronic Heart Failure.稳定型慢性心力衰竭患者冠状窦神经肽 Y 水平与不良结局。
JAMA Cardiol. 2020 Mar 1;5(3):318-325. doi: 10.1001/jamacardio.2019.4717.
9
General and Abdominal Obesity and Incident Distal Sensorimotor Polyneuropathy: Insights Into Inflammatory Biomarkers as Potential Mediators in the KORA F4/FF4 Cohort.一般和腹部肥胖与远端感觉运动多发性神经病的关系:KORA F4/FF4 队列中炎症生物标志物作为潜在介导物的新见解。
Diabetes Care. 2019 Feb;42(2):240-247. doi: 10.2337/dc18-1842. Epub 2018 Dec 6.
10
Lifestyle Indices and Cardiovascular Disease Risk: A Meta-analysis.生活方式指数与心血管疾病风险:一项荟萃分析。
Am J Prev Med. 2018 Oct;55(4):555-564. doi: 10.1016/j.amepre.2018.04.046.